LEADER 01267nam--2200397---450-
001 990001236990203316
005 20090325125133.0
010   $a0-7619-0688-6
035   $a000123699
035   $aUSA01000123699
035   $a(ALEPH)000123699USA01
035   $a000123699
100   $a20031104d2000----km-y0enga50------ba
101 0 $aeng
102   $aUS
105   $ay|||z|||001yy
200 1 $aHarm reduction$enational and international perspectives$fJames A. Inciardi, Lana D. Harrison editors
210   $aThousand Oaks [etc.]$cSage publications$d2000
215   $aXIX, 224 p.$d23 cm.
606 0 $aDroghe$xConsumo$xPrevenzione
606 0 $aSindrome da immunodeficienza acquisita$xPrevenzione
676   $a362.2917
702  1$aINCIARDI,$bJames A.
702  1$aHARRISON,$bLana D.
801  0$aIT$bsalbc$gISBD
912   $a990001236990203316
951   $a362.2 HAR 1 (ISP V 714)$b11329 E.C.$cISP V$d00087637
959   $aBK
969   $aECO
979   $aMARIA$b10$c20031104$lUSA01$h1116
979   $aPATRY$b90$c20040406$lUSA01$h1728
979   $aRENATO$b90$c20050414$lUSA01$h1057
979   $aRENATO$b90$c20050414$lUSA01$h1057
979   $aRSIAV5$b90$c20090325$lUSA01$h1251
996   $aHarm reduction$9987491
997   $aUNISA